From patient positioning and immobilization to workflow fit and reproducible radiotherapy setups, David Holdford has helped build a company around a simple idea: when clinics can trust the setup, everything works better.
Headsafe’s Chief Strategy & Commercial Officer has built Inc. 5000 companies, navigated exits, and mentored a generation of healthcare leaders. Now he is bringing the most disruptive concussion tool in the U.S. market to every clinic and sideline that needs it.
Some of the most compelling stories in MedTech don’t start in a boardroom. They start with a problem no one is taking seriously enough.
Hand surgeon Dr. Kevin Malone on why cost, portability, and access to magnification define the future of surgical care — and what changed the day he first wore a SurgiSight™ device into the OR.
The man who helped build a $701M exit to Stryker is now bringing affordable wearable surgical magnification to hospitals, ambulatory surgery centers, and surgeons who’ve been limited by access to microscopy for far too long.
How Craig Corrance plans to bring Nurochek to the frontlines of mild Traumatic Brain Injury care
Millstone CEO Karl Neuberger on the readiness work OEM teams cannot afford to treat as an afterthought, and why “one PO” changes how complex programs perform.
From legacy brands to a unified vision, CEO Olivier Wolber shares how EXALTA’s integration is unlocking new value for customers worldwide.
Dr. Adrian Cohen shares how his journey from sports fields and rescue helicopters led to Headsafe’s groundbreaking technology, transforming how we diagnose concussions worldwide.
Trusted by 500 institutions and 2,500 surgeons, AROSurgical shows what focus on quality and service can achieve.
